Literature DB >> 3377050

Pupillary dilation in eyes with pseudoexfoliation syndrome.

E F Carpel1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1988        PMID： 3377050     DOI： 10.1016/0002-9394(88)90073-6

Source DB:  PubMed          Journal:  Am J Ophthalmol        ISSN： 0002-9394            Impact factor:   5.258


× No keyword cloud information.
  8 in total

1.  Immunogold localisation of laminin in normal and exfoliative iris.

Authors:  A G Konstas; G E Marshall; W R Lee
Journal:  Br J Ophthalmol       Date:  1990-08       Impact factor: 4.638

2.  Pseudoexfoliation syndrome and secondary cataract.

Authors:  M Küchle; A Amberg; P Martus; N X Nguyen; G O Naumann
Journal:  Br J Ophthalmol       Date:  1997-10       Impact factor: 4.638

3.  Exfoliation syndrome and occludable angles.

Authors:  R Ritch
Journal:  Trans Am Ophthalmol Soc       Date:  1994

4.  Pseudoexfoliation syndrome with poorly dilating pupil: a light and electron microscopic study of the sphincter area.

Authors:  L P Repo; A Naukkarinen; L Paljärvi; M E Teräsvirta
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  1996-03       Impact factor: 3.117

5.  Analysis of Intraoperative and Postoperative Complications in Pseudoexfoliation Eyes Undergoing Cataract Surgery.

Authors:  B C Hemalatha; Sathyendranath B Shetty
Journal:  J Clin Diagn Res       Date:  2016-04-01

6.  Association of Exfoliation Syndrome With Risk of Indirect Inguinal Hernia: The Utah Project on Exfoliation Syndrome.

Authors:  Brian M Besch; Karen Curtin; Robert Ritch; R Rand Allingham; Barbara M Wirostko
Journal:  JAMA Ophthalmol       Date:  2018-12-01       Impact factor: 7.389

7.  Pattern of pseudoexfoliation deposits on the lens and their clinical correlation--clinical study and review of literature.

Authors:  Aparna Rao; Debananda Padhy
Journal:  PLoS One       Date:  2014-12-05       Impact factor: 3.240

8.  Matrix metalloproteinases and their tissue inhibitors after selective laser trabeculoplasty in pseudoexfoliative secondary glaucoma.

Authors:  Mauro Cellini; Pietro Leonetti; Ernesto Strobbe; Emilio C Campos
Journal:  BMC Ophthalmol       Date:  2008-10-21       Impact factor: 2.209
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.